Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levesque

Showing results (51-60 of 281) with videos related to

Pageof 29
Sort By:
Cahiers D'Anesthesiologie|March 1, 1987
[Idiopathic rupture of the bladder]P Levesque, T Marsepoil, F Belotte, et al.
La Revue De Medecine Interne|September 1, 1988
[Malignant hyperthermia electrocardiographic and hemodynamic study]T Marsepoil, P Ho, P Levesque, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
International Journal of Cancer|November 11, 1993
Screening of human bladder tumors and urine sediments for the presence of H-ras mutationsP Levesque, N Ramchurren, K Saini, et al.
The Journal of Investigative Dermatology|July 25, 2017
HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma PatientsYoshihiro Ishida, Atsushi Otsuka, Hidenori Tanaka, et al.
Oncoimmunology|September 19, 2017
MEK inhibition and immune responses in advanced melanomaReinhard Dummer, Egle Ramelyte, Sabrina Schindler, et al.
Journal of Cellular Physiology|August 1, 1987
Evidence for two functionally different fibrinogen receptors on hemopoietic cells: the glycoprotein IIb-IIIa and the mitogenic fibrinogen receptorJ P Levesque, A Hatzfeld, G Hudry-Clergeon, et al.
Expert Opinion on Investigational Drugs|January 9, 2014
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Pageof 29

Showing results (51-60 of 281) with videos related to

Sort By:
Pageof 29
Cahiers D'Anesthesiologie|March 1, 1987
[Idiopathic rupture of the bladder]P Levesque, T Marsepoil, F Belotte, et al.
La Revue De Medecine Interne|September 1, 1988
[Malignant hyperthermia electrocardiographic and hemodynamic study]T Marsepoil, P Ho, P Levesque, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in MelanomaAndrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque, et al.
The Journal of Investigative Dermatology|November 10, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous MelanomaAndreas Dzung, Annalisa Saltari, Natascia Tiso, et al.
Biology Open|May 3, 2018
Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cellsTobias Sinnberg, Heike Niessner, Mitchell P Levesque, et al.
International Journal of Cancer|November 11, 1993
Screening of human bladder tumors and urine sediments for the presence of H-ras mutationsP Levesque, N Ramchurren, K Saini, et al.
The Journal of Investigative Dermatology|July 25, 2017
HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma PatientsYoshihiro Ishida, Atsushi Otsuka, Hidenori Tanaka, et al.
Oncoimmunology|September 19, 2017
MEK inhibition and immune responses in advanced melanomaReinhard Dummer, Egle Ramelyte, Sabrina Schindler, et al.
Journal of Cellular Physiology|August 1, 1987
Evidence for two functionally different fibrinogen receptors on hemopoietic cells: the glycoprotein IIb-IIIa and the mitogenic fibrinogen receptorJ P Levesque, A Hatzfeld, G Hudry-Clergeon, et al.
Expert Opinion on Investigational Drugs|January 9, 2014
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Pageof 29